.png){kind=logo}
Por favor, use este identificador para citar o enlazar este ítem:
https://hdl.handle.net/11000/39485Registro completo de metadatos
| Campo DC | Valor | Lengua/Idioma |
|---|---|---|
| dc.contributor.author | Pérez Catalán, Ignacio | - |
| dc.contributor.author | Gómez‐Alfaro, Iris | - |
| dc.contributor.author | García‐Muñoz, Sergio | - |
| dc.contributor.author | ROIG MARTI, CELIA | - |
| dc.contributor.author | Rodríguez, Noelia Lozano | - |
| dc.contributor.author | Fabra Juana, Sergio | - |
| dc.contributor.author | Esteve Gimeno, Maria José | - |
| dc.contributor.author | Gascón‐Buj, Adriana | - |
| dc.contributor.author | Freiría Alberte, Carmen | - |
| dc.contributor.author | Clavel‐Pia, Juana | - |
| dc.contributor.author | Torres García, Miguel | - |
| dc.contributor.author | REIG-VALERO, ROBERTO | - |
| dc.contributor.author | Ferrando‐Piqueres, Raúl | - |
| dc.contributor.author | MATEU-CAMPOS, MARIA-LIDON | - |
| dc.contributor.author | Usó Blasco, Jorge | - |
| dc.contributor.author | Ramos Rincón, José Manuel | - |
| dc.contributor.other | Departamentos de la UMH::Medicina Clínica | es_ES |
| dc.date.accessioned | 2026-03-05T18:05:20Z | - |
| dc.date.available | 2026-03-05T18:05:20Z | - |
| dc.date.created | 2023 | - |
| dc.identifier.citation | Journal of Medical Virology, Vol. 95, Issue 6 (2023) | es_ES |
| dc.identifier.issn | 1096-9071 | - |
| dc.identifier.issn | 0146-6615 | - |
| dc.identifier.uri | https://hdl.handle.net/11000/39485 | - |
| dc.format | application/pdf | es_ES |
| dc.format.extent | 5 | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | Wiley | es_ES |
| dc.rights | info:eu-repo/semantics/closedAccess | es_ES |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.subject | antiviral treatment | es_ES |
| dc.subject | mAbs | es_ES |
| dc.subject | SARS-COV-2 infection | es_ES |
| dc.subject.other | CDU::6 - Ciencias aplicadas::61 - Medicina | es_ES |
| dc.title | Antiviral treatment or mAbs for persistent SARS‐COV‐2 infection in patients with hematologic malignancies: A case series. | es_ES |
| dc.type | info:eu-repo/semantics/article | es_ES |
| dc.relation.publisherversion | https://doi.org/10.1002/jmv.28865 | es_ES |
Ver/Abrir:Antiviral treatment or mAbs for persistent SARS‐COV‐2 infection in patients with hematologic malignancies. A case series.pdf
496,82 kB
Adobe PDF
Compartir:
La licencia se describe como: Atribución-NonComercial-NoDerivada 4.0 Internacional.